Use our peptide calculator and peptide cost calculator to plan your protocols and budget
This content is for informational purposes and does not replace professional medical advice
Reimbursement for CPT 96372 For 2026, CPT 96372 carries a work RVU (Relative Value Unit) that has been reduced by approximately 2.5% compared to the previous year
The GLP-1 group included people taking medications such as semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda), though the records did not specify exactly which drug each person used
Therefore, tirzepatide treatment increased the percentage of patients within a normal range for cardiovascular risk factors
The most common side issues associated with semaglutide use include gastrointestinal side effects like nausea, diarrhea, vomiting, and constipation